Eosinophilic keratitis

Eosinophilic keratitis is a distinctive inflammatory condition of the feline cornea characterized by the infiltration of eosinophils and other inflammatory cells into the corneal tissue. Eosinophils are white blood cells typically associated with allergic reactions and parasitic infections, and their presence in the cornea creates a unique appearance that distinguishes this condition from other types of keratitis. The condition typically manifests as raised, white to pink, chalky or caseous plaques on the corneal surface, often beginning at the limbus, the junction between the cornea and sclera, and spreading centrally. Eosinophilic keratitis can affect one or both eyes and is considered relatively common among feline corneal diseases.

The exact cause of eosinophilic keratitis remains incompletely understood, but a strong association with feline herpesvirus type 1 has been established. Many cats with eosinophilic keratitis test positive for herpesvirus, suggesting that viral infection triggers or perpetuates the immune-mediated inflammatory response. However, not all affected cats have detectable herpesvirus, indicating that other factors may also initiate the condition. The disease appears to represent an aberrant immune response, possibly an allergic-type reaction, to antigenic stimulation within the cornea. Some researchers consider it part of the feline eosinophilic syndrome that can affect multiple tissues.

The impact of eosinophilic keratitis on affected cats ranges from mild visual impairment to significant vision loss depending on the extent of corneal involvement. The raised plaques are opaque, and when they cover the central visual axis, they substantially block light transmission. Left untreated, the condition tends to progress, with plaques expanding to cover increasingly large portions of the cornea. The inflammatory process can cause discomfort, though affected cats may show surprisingly few pain signs compared to cats with corneal ulcers. Chronic cases may develop permanent corneal scarring and vascularization even after the active disease is controlled.

Eosinophilic keratitis is manageable with appropriate immunosuppressive and anti-inflammatory therapy, though it is often a chronic condition requiring long-term treatment. Most cats respond well initially to topical corticosteroids or other immunomodulatory medications, with plaques resolving over weeks to months. However, recurrence is common when treatment is discontinued, and many cats require maintenance therapy indefinitely. Early diagnosis and treatment minimize permanent corneal damage. With dedicated owner commitment to ongoing management, most cats with eosinophilic keratitis maintain comfortable, functional vision throughout their lives.

The primary causes of eosinophilic keratitis involve immune-mediated inflammation, likely triggered by antigenic stimulation within the cornea. Feline herpesvirus type 1 plays a significant role, with studies detecting viral DNA in the corneas of many affected cats. The virus may initiate the inflammatory process or provide ongoing antigenic stimulation that perpetuates eosinophil recruitment to the cornea. However, the exact mechanism by which herpesvirus triggers this specific eosinophilic response, rather than the more typical lymphocytic inflammation of viral keratitis, remains unclear. Some cats develop eosinophilic keratitis without detectable herpesvirus, suggesting other triggers exist.

Genetic and hereditary factors influencing eosinophilic keratitis susceptibility are not well established. Unlike some corneal conditions, no specific breed predisposition has been clearly documented. The condition appears to occur in cats of any breed, including domestic shorthairs and longhairs. There may be an underlying genetic predisposition to eosinophilic diseases in general, as some cats develop eosinophilic conditions affecting multiple organ systems, but specific genes have not been identified. Family history of eosinophilic disease has not been systematically studied in cats.

Environmental and lifestyle factors may contribute to eosinophilic keratitis development or recurrence. Environmental allergens could theoretically trigger or exacerbate the immune response in predisposed individuals. Stress, which reactivates latent herpesvirus, may precipitate flares in virus-associated cases. Cats in multi-cat environments have increased herpesvirus exposure and transmission. Outdoor access exposes cats to various antigens that might contribute to immune stimulation. However, no specific environmental factors have been definitively linked to eosinophilic keratitis development.

Risk factors for eosinophilic keratitis include previous herpesvirus infection and possibly other immune system characteristics. Young to middle-aged cats appear most commonly affected, though the condition can occur at any age. Cats with history of other eosinophilic diseases, including eosinophilic granuloma complex affecting the skin and oral cavity, may have underlying predisposition to eosinophilic inflammation. Previous corneal disease or trauma might provide the initial antigenic stimulus in some cases. Immunocompromised cats might have altered inflammatory responses, though the relationship is unclear.

The mechanism of eosinophilic keratitis development involves aberrant immune cell recruitment and inflammatory tissue changes. Eosinophils are attracted to the cornea by specific chemical signals, including cytokines and chemokines, produced in response to antigenic stimulation. Once in the cornea, eosinophils release their granular contents, including major basic protein and other inflammatory mediators, which cause tissue damage and recruit additional inflammatory cells. This creates a self-perpetuating cycle of inflammation. The characteristic white, caseous appearance results from accumulated eosinophils, their breakdown products, and associated inflammatory debris within the corneal tissue. Blood vessels grow into the normally avascular cornea as part of the chronic inflammatory response.

Early warning signs of eosinophilic keratitis may be subtle and easily overlooked by cat owners. Initial changes often include mild cloudiness or haziness at the peripheral cornea, near the limbus, that gradually becomes more apparent. A slightly raised or textured area may be noticed before distinct plaque formation. Some cats show mild squinting or increased blinking, though discomfort signs are often less pronounced than with corneal ulcers. The affected eye may have slightly increased tearing. Changes are frequently gradual, developing over weeks to months, which can delay recognition. Bilateral involvement, present in many cases, may develop simultaneously or sequentially.

Common symptoms of established eosinophilic keratitis center on the characteristic corneal plaques. The hallmark finding is one or more raised, white to pink, chalky or cheesy-appearing masses on the corneal surface. These plaques often begin at the limbus and spread centrally, sometimes covering substantial portions of the cornea. The surface may appear irregular or granular. Surrounding the plaques, the cornea often shows vascularization, with blood vessels growing from the limbus toward and into the affected areas. Conjunctival redness and mild mucoid discharge commonly accompany the corneal changes.

Behavioral changes in cats with eosinophilic keratitis are often surprisingly mild given the dramatic corneal appearance. Some cats show minimal discomfort signs and continue normal activities even with substantial corneal involvement. Others may squint intermittently or show mild photophobia. Changes in behavior related to visual impairment, such as hesitation before jumping or bumping into objects, may develop if plaques cover the visual axis. Appetite and activity usually remain normal unless pain or vision loss is significant. The relatively subtle behavioral signs can contribute to delayed recognition of the condition.

Physical signs observable during examination provide diagnostic information. The corneal plaques have a characteristic appearance distinct from other corneal conditions, appearing as raised, white to pink, caseous material adherent to the corneal surface. Vascularization is typically present, with vessels extending from the limbus into the affected area. The conjunctiva usually shows mild to moderate hyperemia. There may be mild corneal edema surrounding the plaques. The third eyelid may be slightly elevated in some cases. The pupil typically remains reactive, and the interior of the eye usually appears normal unless secondary changes have developed.

Symptom progression in untreated eosinophilic keratitis follows a predictable pattern. Plaques tend to expand over time, covering increasingly large areas of the cornea. As central corneal involvement increases, vision becomes progressively impaired. Vascularization increases with chronicity. The plaques may become thicker and more confluent. Without treatment, the condition can eventually affect the entire corneal surface. Chronic inflammation may lead to permanent corneal scarring and opacity that persists even after active disease is controlled. Rarely, severely affected corneas may develop secondary complications including ulceration.

Emergency symptoms requiring prompt attention are less common with eosinophilic keratitis than with some other corneal conditions, as this is typically a chronic, slowly progressive disease. However, sudden increase in pain, development of obvious ulceration visible as a defect in the plaque surface, or dramatic increase in discharge warrants urgent evaluation. If the eye appears suddenly more swollen or the cat becomes acutely distressed, secondary complications may have developed. Any cat with previously stable disease that suddenly worsens should be examined promptly. While rarely a true emergency, delays in treatment allow preventable progression and permanent damage.

Initial examination for suspected eosinophilic keratitis begins with a complete ophthalmic evaluation. The veterinarian takes a detailed history including onset and progression of corneal changes, any previous eye problems, and whether other signs of eosinophilic disease have been noted. Both eyes are examined carefully, as bilateral involvement is common. The characteristic appearance of eosinophilic keratitis, with its raised, white to pink, caseous plaques typically beginning at the limbus, is often clinically distinctive enough to suggest the diagnosis on visual examination alone. The extent of corneal involvement, degree of vascularization, and status of surrounding structures are documented.

Diagnostic tests confirm the diagnosis and evaluate for underlying causes. Corneal cytology is the definitive diagnostic test, obtained by gently scraping the surface of the plaques and examining the cells microscopically. The finding of numerous eosinophils, often with other inflammatory cells including mast cells and lymphocytes, confirms the diagnosis. Fluorescein staining evaluates for concurrent corneal ulceration, which may occur but is not typical. Testing for feline herpesvirus through PCR may be performed given the strong association, though results do not necessarily change treatment. The Schirmer tear test and tonometry are performed to rule out contributing factors.

Differential diagnosis considers other conditions causing raised corneal lesions or opacities. Corneal sequestrum, though typically darker and more focal, might be confused with early eosinophilic keratitis in atypical cases. Corneal granulation tissue following ulcer healing could appear similar but has different history. Corneal lipid or calcium deposits are typically bilateral, crystalline, and not raised. Corneal neoplasia is rare but should be considered for atypical, progressive lesions. Chronic superficial keratitis has similar distribution but different cellular composition. Cytological examination definitively distinguishes eosinophilic keratitis from these conditions.

Diagnosis confirmation integrates clinical appearance with cytological findings. The combination of characteristic raised, caseous plaques with cytological confirmation of eosinophilic infiltration is diagnostic. Once confirmed, evaluation for potential underlying causes or concurrent conditions is completed. Testing for herpesvirus may guide treatment decisions, though many practitioners treat empirically with antivirals regardless of test results. Evaluation for other manifestations of eosinophilic disease, including skin lesions or oral plaques, provides comprehensive patient assessment. Discussion of the chronic nature of the condition and need for long-term management prepares owners for what to expect.

Emergency treatment is rarely required for eosinophilic keratitis, as this is typically a chronic condition rather than an acute emergency. However, when diagnosis is made, prompt treatment initiation prevents progression and limits permanent damage. If concurrent corneal ulceration is present, this is addressed with appropriate therapy. The primary goal of initial treatment is to suppress the inflammatory response and begin resolution of the corneal plaques. An Elizabethan collar may be placed if the cat is rubbing at the affected eye, though this is less commonly needed than with more painful corneal conditions.

Medical management is the mainstay of eosinophilic keratitis treatment. Topical corticosteroids are the primary therapy, with prednisolone acetate or dexamethasone applied multiple times daily until plaques begin to resolve. Megestrol acetate, an oral progestational hormone, was historically used and is effective but carries significant side effects including diabetes mellitus and mammary neoplasia, so its use has declined. Topical cyclosporine or tacrolimus, calcineurin inhibitors with immunomodulatory effects, are increasingly used either alone or in combination with corticosteroids. Concurrent antiviral therapy with topical cidofovir or systemic famciclovir addresses potential herpesvirus involvement.

Surgical intervention is rarely required for eosinophilic keratitis. Superficial keratectomy to remove plaques may be considered for cases refractory to medical management or where plaques are very thick. However, surgical removal alone does not address the underlying immune dysregulation, and recurrence is likely without ongoing medical therapy. Surgery may also be indicated if secondary complications such as ulceration or perforation develop. Cryotherapy or other ablative techniques have been attempted but are not standard care. Most cases are managed medically without surgery.

Supportive care complements primary anti-inflammatory treatment. Lubricating eye drops or ointments help maintain corneal surface health. If concurrent dry eye is present, appropriate tear supplementation is essential. Minimizing environmental stress may reduce herpesvirus reactivation in affected cats. Nutritional support with omega-3 fatty acids may have mild anti-inflammatory benefits. Maintaining overall health supports immune function. Environmental modifications to reduce allergen exposure might help in some cases, though specific triggers are rarely identified.

Alternative and complementary approaches may be considered when standard treatments are insufficient or contraindicated. Topical interferon has been used with some success for feline ocular surface disease. Subconjunctival corticosteroid injections provide localized treatment with potentially less systemic absorption than oral medications. L-lysine supplementation is often recommended for herpesvirus-associated disease, though evidence for efficacy is limited. Some practitioners explore dietary modification or elimination trials if allergic triggers are suspected. These approaches supplement rather than replace primary anti-inflammatory treatment.

Treatment decision factors include disease severity, response to initial therapy, and owner ability to administer chronic medications. Mild cases may be controllable with less intensive therapy, while severe or refractory cases require aggressive treatment. Steroid side effects, including risk of corneal ulceration if herpesvirus is active, must be balanced against treatment benefits. The chronic nature of the disease means owners must be prepared for long-term medication costs and administration. For cats that cannot tolerate topical medications, oral or injectable alternatives may be needed. Open discussion of the likely need for maintenance therapy sets appropriate expectations.

Recovery timeline for eosinophilic keratitis involves resolution of active inflammation, which typically occurs over weeks to months with appropriate treatment. Initial improvement is often visible within one to two weeks of starting therapy, with plaques becoming less raised and less opaque. Complete resolution of active plaques may take one to three months depending on initial severity. However, eosinophilic keratitis is characteristically a chronic condition, and recovery from an acute flare does not imply cure. Many cats require ongoing maintenance therapy to prevent recurrence, making lifelong management more accurate than recovery for most cases.

Post-treatment care for eosinophilic keratitis involves gradual medication tapering and long-term monitoring. Once active plaques have resolved, treatment frequency is slowly reduced rather than abruptly discontinued. Many cats require some level of maintenance therapy indefinitely to prevent recurrence. Recheck examinations monitor for early signs of disease recurrence, typically scheduled monthly during initial treatment, then extending to every three to six months for stable cases on maintenance therapy. Owners learn to recognize early recurrence signs so treatment can be intensified promptly when needed.

Prognosis factors for eosinophilic keratitis relate to disease severity at diagnosis, treatment response, and ability to maintain long-term therapy. Cats diagnosed early with limited corneal involvement and good treatment response have favorable prognoses for maintaining functional vision. Those with extensive corneal involvement or delayed treatment may have permanent scarring affecting vision. Treatment response varies, with some cats responding quickly to standard therapy while others require combination approaches or alternative medications. Owner compliance with chronic treatment protocols significantly affects long-term outcomes.

Long-term outlook for cats with eosinophilic keratitis is generally good with appropriate management. Most cats maintain comfortable, functional vision with ongoing treatment. Recurrence is common, occurring in the majority of cases when treatment is discontinued and in many cases even with maintenance therapy. However, prompt recognition and treatment of flares minimizes additional permanent damage. Some cats eventually achieve stable remission with reduced or discontinued treatment, though predicting which cats will do so is difficult. The condition is typically manageable rather than curable, requiring owner acceptance of chronic disease management.

Primary prevention of eosinophilic keratitis is challenging because the underlying causes are not fully understood. Reducing herpesvirus exposure by keeping cats indoors and limiting contact with potentially infected cats may decrease risk for uninfected cats. Supporting immune health through good nutrition and stress minimization might reduce susceptibility. For cats with history of eosinophilic keratitis, preventing recurrence becomes the focus, achieved through ongoing maintenance therapy as recommended by the treating veterinarian. There is no proven way to prevent initial development in predisposed individuals.

Environmental prevention focuses on minimizing potential triggers for immune-mediated inflammation. Reducing environmental stress may decrease herpesvirus reactivation in carrier cats. Keeping cats indoors limits exposure to outdoor allergens and antigens that might trigger responses in susceptible individuals. Maintaining clean living environments with regular removal of dust and potential irritants supports ocular health. Using unscented litter and avoiding aerosol products near cats reduces potential irritant exposure. These measures are generally supportive of eye health though not proven to prevent eosinophilic keratitis specifically.

Dietary prevention through optimal nutrition supports overall immune health. Complete and balanced nutrition appropriate for the cat's life stage provides necessary nutrients for immune function and tissue health. Omega-3 fatty acid supplementation may have mild anti-inflammatory effects. L-lysine supplementation is often recommended for cats with herpesvirus history, though evidence for efficacy in preventing eosinophilic keratitis specifically is lacking. Avoiding nutritional deficiencies that could compromise immune regulation might reduce susceptibility. Adequate hydration supports mucous membrane health.

Health maintenance through regular veterinary care enables early detection of eosinophilic keratitis and other conditions. Annual wellness examinations should include thorough eye evaluation. For cats with history of the condition, more frequent monitoring allows early detection of recurrence. Promptly addressing any eye abnormality prevents progression of early disease. Managing any concurrent conditions optimally supports overall health. Regular parasite prevention maintains immune resources for other challenges.

Early intervention when symptoms develop prevents severe corneal damage. Owners should learn to recognize early signs of eosinophilic keratitis, including peripheral corneal cloudiness, mild pink or white discoloration, and subtle vascularization. Any abnormal corneal appearance warrants veterinary evaluation. For cats with previous episodes, maintaining maintenance therapy as prescribed and increasing treatment intensity at the first sign of recurrence prevents significant progression. Waiting to see if mild symptoms resolve on their own allows preventable worsening. Partnership between informed owners and veterinary professionals optimizes outcomes.

Daily management of cats with eosinophilic keratitis centers on consistent medication administration. Topical medications typically require application one to four times daily depending on disease phase and specific medications prescribed. Establishing a routine that works with the owner's schedule improves compliance. Owners should learn proper technique for administering eye drops or ointments, including approaching the cat calmly, restraining gently, and applying medication without touching the dropper or tube to the eye. Daily visual inspection of the corneas helps detect early changes suggesting recurrence or complications.

Home environment modifications support cats with this chronic condition. Maintaining consistent low-stress environments reduces herpesvirus reactivation risk in carrier cats. Providing environmental enrichment helps maintain quality of life. Keeping food, water, and litter boxes easily accessible accommodates any vision impairment. Using nightlights in key areas helps cats with reduced vision navigate in low light. For multi-cat households, ensuring peaceful coexistence through adequate resources and space minimizes stress. Clean environments with minimal dust and irritants support ocular health.

Quality of life remains good for most cats with managed eosinophilic keratitis. With appropriate treatment, most cats maintain comfortable, functional vision and continue normal activities. The condition is generally not painful when controlled, allowing cats to enjoy play, interaction, and enrichment as usual. For cats with some permanent corneal scarring affecting vision, environmental accommodations and the cat's natural adaptation abilities typically maintain quality of life. Continuing to engage cats in appropriate activities supports mental and physical health regardless of visual status.

Monitoring and ongoing care ensure disease control and early detection of complications. Regular veterinary rechecks, typically every one to three months for stable cases, monitor disease status and allow medication adjustments. Owners should know the signs of recurrence, including increased corneal cloudiness, new raised areas, or redness. Any changes should prompt veterinary evaluation rather than waiting for the next scheduled appointment. Keeping detailed records of medication administration and any observed changes helps guide treatment decisions.

Caregiver support resources help owners manage the challenges of chronic eye disease. Veterinary staff can demonstrate medication techniques and provide encouragement. Written schedules and instructions help maintain compliance with treatment protocols. Online communities connect owners of cats with similar conditions, providing practical tips and emotional support. Understanding that this is typically a manageable chronic condition rather than a curable disease helps set appropriate expectations. Financial planning for ongoing medication costs reduces stress. Celebrating stable periods and accepting that flares may occur despite best efforts maintains positive perspective.

High-risk breeds for eosinophilic keratitis have not been definitively established, as the condition appears to occur across all feline breeds with similar frequency. Unlike some corneal conditions with clear breed predispositions, eosinophilic keratitis does not preferentially affect brachycephalic or other specific breed types. Domestic shorthairs and longhairs are commonly affected, likely reflecting their prevalence in the general cat population rather than specific susceptibility. Some reports suggest possible increased occurrence in certain geographic regions, but breed predisposition has not been confirmed.

Moderate-risk categories are similarly not well defined for eosinophilic keratitis. Young to middle-aged cats appear most commonly affected, suggesting possible age-related risk factors rather than breed-related ones. Cats with history of herpesvirus infection may have increased susceptibility due to the association between the virus and eosinophilic keratitis. Cats with other manifestations of eosinophilic syndrome, including eosinophilic granuloma complex or eosinophilic enteritis, might have underlying predisposition to eosinophilic inflammation. However, these associations have not been extensively studied.

Screening recommendations focus on cats with risk factors rather than specific breeds. Cats with history of herpesvirus-related eye disease should be monitored for development of eosinophilic keratitis as a potential complication. Those with previous episodes require ongoing monitoring for recurrence. Any cat showing early signs of corneal cloudiness, particularly with the characteristic peripheral distribution and caseous appearance, should be evaluated promptly. Regular wellness examinations including eye evaluation allow early detection in all cats regardless of breed. Since breed prediction is not possible, vigilance for clinical signs in any cat remains the best approach.

Commonly co-occurring conditions with eosinophilic keratitis often relate to shared underlying factors. Feline herpesvirus keratitis frequently coexists with eosinophilic keratitis and may represent a trigger or contributing factor. Conjunctivitis, whether viral, allergic, or eosinophilic, commonly accompanies the corneal disease. Eosinophilic granuloma complex affecting the skin and oral cavity may occur in cats with eosinophilic keratitis, suggesting possible systemic predisposition to eosinophilic inflammation. Upper respiratory disease from herpesvirus may occur concurrently, especially during stress-induced viral reactivation. Managing these concurrent conditions optimizes overall health.

Conditions with similar symptoms require differentiation from eosinophilic keratitis. Chronic superficial keratitis causes similar vascularization and opacity but has different cellular infiltration on cytology. Corneal sequestrum creates raised corneal lesions but appears brown to black rather than white to pink. Corneal lipid dystrophy causes white corneal deposits but typically appears crystalline and flat rather than caseous and raised. Feline herpesvirus keratitis alone causes corneal cloudiness and vascularization but lacks the characteristic eosinophilic plaques. Corneal neoplasia, though rare, should be considered for atypical progressive lesions. Cytological examination distinguishes these conditions.

Potential complications of eosinophilic keratitis primarily involve permanent corneal damage from chronic inflammation. Corneal scarring, appearing as persistent opacity even after active disease is controlled, is common and may impair vision if centrally located. Corneal vascularization tends to persist to some degree after resolution of acute inflammation. Rarely, secondary corneal ulceration may develop within affected areas. Chronic steroid treatment increases ulceration risk if herpesvirus reactivates. Recurrence of active disease, though more a characteristic of the condition than a complication, causes cumulative corneal damage over time. Regular monitoring and maintenance therapy minimize complications.